The Ellison Medical Institute (EMI) has entered into an exclusive license with UniQuest, the commercialization company of The ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

A pioneering blood test detected more than twice as many high-risk prostate cancer cases as current methods, paving the way for more effective screening.

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

A multimodal AI model identified a subset of men with very high-risk localized prostate cancer who derived substantial ...

Prostate cancer is one of the most common cancers diagnosed in men. Although it is the second-leading cause of cancer-related deaths for men in the U.S., it is also highly treatable, especially when ...

Prostate cancer is a disease in which cancer cells form in the tissues of the prostate, a gland in the male reproductive system. The National Cancer Institute states that about 1 in 8 males will be ...

The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute’s (NCI) Specialized Programs of ...

According to the National Cancer Institute, Black men in the U.S. are diagnosed with prostate cancer at a much higher rate ...